FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793670714> ?p ?o ?g. }

• W2793670714 endingPage "1659" @default.
• W2793670714 startingPage "1648" @default.
• W2793670714 abstract "Oncogene c‐Src has been found to be a potential target for the treatment of triple‐negative breast cancer ( TNBC ). However, the therapeutic effects of the c‐Src inhibitor on TNBC patients are controversial compared to those on cell lines. The molecular mechanisms of the inhibitory effects of the c‐Src inhibitor on TNBC remain unclear. Herein, we showed that a specific c‐Src inhibitor, PP 2, was effective in inhibiting phosphorylation of c‐Src in 4 cell lines: T‐47D, SK ‐ BR ‐3, SUM 1315 MO 2, and MDA ‐ MB ‐231, regardless of hormone receptors and human epidermal growth factor receptor 2 ( HER 2) expression levels. Giving PP 2 preferentially reduced the S phase of cell cycles and inhibited colony formation in SUM 1315 MO 2 and MDA ‐ MB ‐231, but not in SK ‐ BR ‐3 and T‐47D cells. Furthermore, PP 2 effectively blocked cell migration/invasion and epithelial‐mesenchymal transition ( EMT ) in TNBC cell lines, SUM 1315 MO 2 and MDA ‐ MB ‐231. An EMT biomarker, vimentin, was highly expressed in 2 TNBC cell lines when they were compared with SK ‐ BR ‐3 and T‐47D cells. Further depletion of vimentin by sh RNA remarkably attenuated the inhibitory effects of the c‐Src inhibitor on TNBC cells in vitro and in vivo, indicating a crucial action of vimentin to affect the function of c‐Src in TNBC . This study provides an important rationale for the clinic to precisely select TNBC patients who would benefit from c‐Src inhibitor treatment. This finding suggests that traditional markers for TNBC are not sufficient to precisely define this aggressive type of cancer. Vimentin is identified as an important biomarker to enable categorization of TNBC ." @default.
• W2793670714 created "2018-03-29" @default.
• W2793670714 creator A5012889835 @default.
• W2793670714 creator A5031110963 @default.
• W2793670714 creator A5036860312 @default.
• W2793670714 creator A5041166642 @default.
• W2793670714 creator A5074720025 @default.
• W2793670714 date "2018-04-17" @default.
• W2793670714 modified "2023-10-17" @default.
• W2793670714 title "c‐Src inhibitor selectively inhibits triple‐negative breast cancer overexpressed Vimentin in vitro and in vivo" @default.
• W2793670714 cites W1550675315 @default.
• W2793670714 cites W1586327679 @default.
• W2793670714 cites W1589166971 @default.
• W2793670714 cites W1590055389 @default.
• W2793670714 cites W1969346276 @default.
• W2793670714 cites W1970079141 @default.
• W2793670714 cites W1970336788 @default.
• W2793670714 cites W1988698939 @default.
• W2793670714 cites W1995625056 @default.
• W2793670714 cites W1996331246 @default.
• W2793670714 cites W2000596607 @default.
• W2793670714 cites W2012095617 @default.
• W2793670714 cites W2031096972 @default.
• W2793670714 cites W2036988959 @default.
• W2793670714 cites W2063382533 @default.
• W2793670714 cites W2070168751 @default.
• W2793670714 cites W2073051491 @default.
• W2793670714 cites W2076102215 @default.
• W2793670714 cites W2087367170 @default.
• W2793670714 cites W2091091648 @default.
• W2793670714 cites W2096027508 @default.
• W2793670714 cites W2096283457 @default.
• W2793670714 cites W2097208900 @default.
• W2793670714 cites W2097255042 @default.
• W2793670714 cites W2102702938 @default.
• W2793670714 cites W2105374417 @default.
• W2793670714 cites W2107931058 @default.
• W2793670714 cites W2109462974 @default.
• W2793670714 cites W2116309119 @default.
• W2793670714 cites W2117692326 @default.
• W2793670714 cites W2127714324 @default.
• W2793670714 cites W2134539328 @default.
• W2793670714 cites W2142739240 @default.
• W2793670714 cites W2157840751 @default.
• W2793670714 cites W2161743151 @default.
• W2793670714 cites W2165901622 @default.
• W2793670714 cites W2235997771 @default.
• W2793670714 cites W2346684212 @default.
• W2793670714 cites W2401486361 @default.
• W2793670714 cites W2407627822 @default.
• W2793670714 cites W2500055318 @default.
• W2793670714 cites W2514567198 @default.
• W2793670714 cites W2560836545 @default.
• W2793670714 doi "https://doi.org/10.1111/cas.13572" @default.
• W2793670714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5980174" @default.
• W2793670714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29575318" @default.
• W2793670714 hasPublicationYear "2018" @default.
• W2793670714 type Work @default.
• W2793670714 sameAs 2793670714 @default.
• W2793670714 citedByCount "22" @default.
• W2793670714 countsByYear W27936707142019 @default.
• W2793670714 countsByYear W27936707142020 @default.
• W2793670714 countsByYear W27936707142021 @default.
• W2793670714 countsByYear W27936707142022 @default.
• W2793670714 countsByYear W27936707142023 @default.
• W2793670714 crossrefType "journal-article" @default.
• W2793670714 hasAuthorship W2793670714A5012889835 @default.
• W2793670714 hasAuthorship W2793670714A5031110963 @default.
• W2793670714 hasAuthorship W2793670714A5036860312 @default.
• W2793670714 hasAuthorship W2793670714A5041166642 @default.
• W2793670714 hasAuthorship W2793670714A5074720025 @default.
• W2793670714 hasBestOaLocation W27936707141 @default.
• W2793670714 hasConcept C108636557 @default.
• W2793670714 hasConcept C11960822 @default.
• W2793670714 hasConcept C121608353 @default.
• W2793670714 hasConcept C147447768 @default.
• W2793670714 hasConcept C1491633281 @default.
• W2793670714 hasConcept C153911025 @default.
• W2793670714 hasConcept C185592680 @default.
• W2793670714 hasConcept C203014093 @default.
• W2793670714 hasConcept C204232928 @default.
• W2793670714 hasConcept C2779013556 @default.
• W2793670714 hasConcept C2780110267 @default.
• W2793670714 hasConcept C2781018059 @default.
• W2793670714 hasConcept C29537977 @default.
• W2793670714 hasConcept C502942594 @default.
• W2793670714 hasConcept C530470458 @default.
• W2793670714 hasConcept C54355233 @default.
• W2793670714 hasConcept C55493867 @default.
• W2793670714 hasConcept C76419328 @default.
• W2793670714 hasConcept C81885089 @default.
• W2793670714 hasConcept C86803240 @default.
• W2793670714 hasConcept C95444343 @default.
• W2793670714 hasConceptScore W2793670714C108636557 @default.
• W2793670714 hasConceptScore W2793670714C11960822 @default.
• W2793670714 hasConceptScore W2793670714C121608353 @default.
• W2793670714 hasConceptScore W2793670714C147447768 @default.
• W2793670714 hasConceptScore W2793670714C1491633281 @default.

• next